⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
CoEffex Launches to Redefine Leadership Development with Data-Driven Coaching for High Growth Companies
prnewswire.com
GNK
NVS
RGNX
Low Carbon Building Market Set to Reach US$ 2,049.2 Billion by 2035 | Astute Analytica
globenewswire.com
HEI
JLL
CBRE
KGS
DD
SPG
PLD
MAS
GE
HON
MMM
AXP
MS
GS
JPM
BAC
WFC
SCHW
BLK
V
MA
IBM
MSFT
GOOG
AMZN
NVDA
INTC
AMD
CRM
ADBE
QCOM
MU
AMAT
LRCX
ASML
ADI
TXN
NXPI
MRVL
SNPS
CDNS
FFIV
NOW
PANW
CRWD
ZS
FTNT
ETSY
PYPL
COIN
UBER
LYFT
NFLX
DIS
CMCSA
VZ
T
S
DDOG
MCHP
ON
SWKS
ALGN
REGN
GILD
AMGN
BIIB
AZN
NVS
XSW
RIVN
LCID
FSLR
SEDG
ENPH
NEE
BE
PLUG
FCEL
VVX
AVAV
ROKU
UPST
SOFI
HOOD
AFRM
RDFI
Z
RCL
CCL
NCLH
LULU
NKE
UA
M
KSS
TJX
BBY
WMT
HD
LOW
MASI
ADSK
ACN
XOM
CVX
SRE
DUK
SO
PCG
ED
AEP
EXC
NRG
EIX
WEC
D
XEL
CHPT
EVGO
BLNK
PLTR
SNOW
Pharma Supply Chain & Security World Returns to London: Building a Connected and Resilient Ecosystem
globenewswire.com
PFE
ALNY
BMY
NVS
GSK
Respiratory Inhaler Devices Market to Reach $51.9 billion, Globally, by 2034 at 4.8% CAGR: Allied Market Research
prnewswire.com
AZN
BIIB
TEVA
NVS
GSK
SUN
Chemical Synthesis Peptide Drugs Market Set to Reach USD 4.82 Billion by 2034, Growing at a 6.54% CAGR Driven by Automation and Green Chemistry Advances
globenewswire.com
LLY
NVS
MRK
Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer USA - English USA - English
prnewswire.com
EXAS
NVS
Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer USA - English USA - English
prnewswire.com
EXAS
NVS
CytoAgents Appoints Dr. Johannes Wolff as Chief Medical Officer and Michael Howell as Chief Scientific Officer
businesswire.com
RPRX
ABBV
NVS
ZURA
INCY
AZN
Vertigo Drugs Market Outlook Report 2026-2034 - Landscape Shift Towards Targeted Drug Regimens Over Blanket Suppression, Emphasizing Early Rehab and Non-Sedating Prophylactics - ResearchAndMarkets.com
businesswire.com
ABT
SNY
PFE
GSK
NVS
Diabetic Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2031 - APAC Leads Industry Growth as Demand for Pain Management Soars - ResearchAndMarkets.com
businesswire.com
PFE
JNJ
LLY
GSK
NVS